Lenisna PDLLA

LENISNA is a combination filler that links the advantages of both hyaluronic acid (HA) and Poly D,L-lactide (PDLLA). It provides the instant filling effects of HA, as HA can immediately add volume when injected. Additionally, LENISNA supplies the long-lasting collagen stimulation effects of PDLLA. Over time, PDLLA encourages collagen production in treated areas for sustained wrinkle correction and volumisation. This patented technology hybrid filler offers fast visible plumping from the HA component along with collagen boosting effects for longer-term enhancement courtesy of the PDLLA portion.

LENISNA consists of 170 mg of poly D,L-lactide (PDLLA) polylactic acid and 30 mg of non-crosslinked hyaluronic acid. The particle size of the PDLLA ranges from 50 to 60 micrometers. By customizing the concentration and particle dimensions and blending with unmodified hyaluronic acid, this hybrid filler is suitable for injection into the subcutaneous tissues or periosteum.

The intended uses of LENISNA are treating deep wrinkles, skin laxity, and substantial tissue defects.

Due to the combination of PDLLA polylactic acid and hyaluronic acid (HA), LENISNA provides visible results straight after the treatment.

The initial filling impact persists until the polylactic acid stimulates new collagen and elastin production. The volumizing effects from the collagen and elastin synthesis then maintains the enhancement over time. LENISNA leverages both instant and longer-lasting filling effects for an immediate visible improvement that is sustained.
Lenisna’s distinctive capacity lies in its unparalleled collagen-boosting properties that gradually restore a youthful look over time. The round-shaped PDLLA acid molecules integrated with non-crosslinked hyaluronic acid enable Lensina to stimulate collagen synthesis to the maximum extent possible.

Enduring effects that continue for over 24 months from the final treatment. The enhancements can be prolonged by performing one follow-up session after the 12-24-month mark. This allows individuals to maintain their refreshed appearance with less frequent touch-ups.

Treatment guide: suggested 1 vial per session for 3 sessions, with 1-month interval. Retreatment – after 1 year.

In essence, Lenisna’s ability to foster significant natural collagen formation paired with infrequent maintenance requirements delivers progressive, lasting, and natural-looking facial rejuvenation for the long term. The fusion of PDLLA and non-crosslinked HA enables optimal collagen stimulation while avoiding overtreatment and delivering natural results.